| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014459 |
| Receipt No. | R000016821 |
| Official scientific title of the study | effect of lid hygiene on meibomian gland dysfunction |
| Date of disclosure of the study information | 2014/07/03 |
| Last modified on | 2016/04/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | effect of lid hygiene on meibomian gland dysfunction | |
| Title of the study (Brief title) | effect of lid hygiene on meibomian gland dysfunction | |
| Region |
|
|
| Condition | ||
| Condition | meibomian gland dysfunction | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the treatment efficacy and safety of lid hygiene on meibomian gland dysfunction |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | subjective symptom, tear breakup time, fluorescein staining score, meibum, lid margin findings |
| Key secondary outcomes | DR1, functional visual acuity, confocal microscopy |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | lid hygiene using eye shampoo | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | meibomian gland dysfunction | |||
| Key exclusion criteria | patient with severe ocular surface disease
patient who had ocular surgery within 1 month |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Motoko Kawashima |
| Organization | Keio University School of Medicine |
| Division name | Department of Ophthalmology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan |
| TEL | 81333531211 |
| motoko326@gmail.com | |
| Public contact | |
| Name of contact person | Motoko Kawashima |
| Organization | Keio University School of Medicine |
| Division name | Ophthalmology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan |
| TEL | 81333531211(63954) |
| Homepage URL | |
| motoko326@gmail.com | |
| Sponsor | |
| Institute | Department of Ophthalmology, Keio University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | mediproduct |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000016821 |